UK considerations NHS and MHRA guidance The UK health authorities have clear positions on weight loss treatments: The NHS offers GLP-1 medications through specialist weight management services for eligible patients MHRA has approved Wegovy, Saxenda, and Mounjaro based on comprehensive safety and efficacy data No GLP-1 patch products have received MHRA approval as weight loss treatments The MHRA has issued warnings about misleading claims in weight loss supplements Cost and access in the UK The financial aspect is a significant consideration for many: NHS provision : Limited availability through specialist weight management services with strict eligibility criteria Private prescriptions : 150-300 monthly, depending on medication and provider Commercial patches : 12-70 monthly, depending on brand and quantity While patches appear less expensive, they lack evidence of effectiveness, making them poor value regardless of price
This medicine is a GLP-1 receptor agonist
Participants spent an average of 2.7 hours outdoors each day, and daily pollen counts ranged from less than 20 grains/m 3 to more than 100 grains/m 3 during the treatment period
Simply amazing
Bears are watching Foundayo (orforglipron), Lillys newly launched oral GLP-1 weight-loss pill
Healthy fats also provide steady energy, making them an excellent addition to your meals to help you feel your best throughout the day